Sunitinib-induced endocapillary proliferative glomerulonephritis with IgA2 deposit in addition to thrombotic microangiopathy: a case report
This case highlights the complex interplay between the therapeutic effects of sunitinib and its potential renal and cardiovascular toxicities, emphasizing the need for close monitoring and effective management strategies to optimize patient outcomes.
Authors
- Ming‐Hui Zhao (ORCID: https://orcid.org/0000-0003-3340-3108)
- Fude Zhou (ORCID: https://orcid.org/0000-0002-6355-4946)
- Tao Su (ORCID: https://orcid.org/0000-0002-6857-8146)
- Xin Zhang (ORCID: https://orcid.org/0000-0003-4099-6175)
- Jian Li (ORCID: https://orcid.org/0000-0003-3320-7924)
- H Wang (ORCID: https://orcid.org/0009-0007-4601-1492)
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Ministry of Education (SA)
- Peking University People's Hospital (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1186/s12882-024-03732-6
- Citations
- 1
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.44
Funders
- Peking University First Hospital
- Peking University